CGEM — Cullinan Therapeutics Share News
0.000.00%
Last trade - 00:00- $960.17m
- $625.63m
U.S. STOCKS ON THE MOVE-Premier, Canadian Solar, Jabil
U.S. STOCKS ON THE MOVE-Premier, Canadian Solar, Jabil
Cullinan Oncology rises as TD Cowen starts coverage with 'outperform'
Cullinan Oncology Inc reports results for the quarter ended in March - Earnings Summary
Brief: Cullinan Oncology Reports First Quarter 2023 Financial Results
Brief: Cullinan Oncology Q1 adjusted net loss USD 58.1 million
Brief: Cullinan Oncology Announces U.S. FDA Clearance Of Investigational New Drug Application For CLN-617
ORIC Pharma rises as H.C.Wainwright upgrades to 'buy' on cancer drug potential
Brief: Cullinan Oncology Inc Files For Mixed Shelf Of Up To $350 Million – SEC Filing
Brief: Cullinan Oncology Reports Fourth Quarter And Full Year 2022 Financial Results
HK-listed HBM jumps on licensing deal with Cullinan Oncology
U.S. STOCKS ON THE MOVE-Baudax Bio , GATX Corp, Verb Technology, Decibel Therapeutics
U.S. STOCKS ON THE MOVE-PACCAR, Cullinan Oncology, 3M, Peloton
Cullinan Oncology rises on FDA's nod for cancer drug trial in humans
Brief: Cullinan Oncology Announces U.S. FDA Clearance Of Investigational New Drug Application For Cln-978, A Novel T-Cell Engager For The Treatment Of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
U.S. STOCKS ON THE MOVE-Blue Water, Domino's Pizza, Tesla
Cullinan Oncology shares rise as BTIG starts coverage with 'buy'
U.S. STOCKS ON THE MOVE-China ADRs, silver stocks, Canadian Solar
Cullinan Oncology shares get 'buy' rating as BTIG starts coverage